244 related articles for article (PubMed ID: 28793245)
1. SOX2 Is a Marker for Stem-like Tumor Cells in Bladder Cancer.
Zhu F; Qian W; Zhang H; Liang Y; Wu M; Zhang Y; Zhang X; Gao Q; Li Y
Stem Cell Reports; 2017 Aug; 9(2):429-437. PubMed ID: 28793245
[TBL] [Abstract][Full Text] [Related]
2. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma.
Boumahdi S; Driessens G; Lapouge G; Rorive S; Nassar D; Le Mercier M; Delatte B; Caauwe A; Lenglez S; Nkusi E; Brohée S; Salmon I; Dubois C; del Marmol V; Fuks F; Beck B; Blanpain C
Nature; 2014 Jul; 511(7508):246-50. PubMed ID: 24909994
[TBL] [Abstract][Full Text] [Related]
3. Relevance of iNOS expression in tumor growth and maintenance of cancer stem cells in a bladder cancer model.
Belgorosky D; Girouard J; Langle YV; Hamelin-Morrissete J; Marino L; Agüero EI; Malagrino H; Reyes-Moreno C; Eiján AM
J Mol Med (Berl); 2020 Nov; 98(11):1615-1627. PubMed ID: 32955679
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer cells with positive Sox2 expression exhibit the properties of cancer stem cells.
Liu XF; Yang WT; Xu R; Liu JT; Zheng PS
PLoS One; 2014; 9(1):e87092. PubMed ID: 24489842
[TBL] [Abstract][Full Text] [Related]
5. Cell division patterns and chromosomal segregation defects in oral cancer stem cells.
Kaseb HO; Lewis DW; Saunders WS; Gollin SM
Genes Chromosomes Cancer; 2016 Sep; 55(9):694-709. PubMed ID: 27123539
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA AK023096 interacts with hnRNP-K and contributes to the maintenance of self-renewal in bladder cancer stem-like cells.
Zhao F; Qin S; Huang L; Ding L; Shi X; Zhong G
Exp Cell Res; 2021 Dec; 409(2):112909. PubMed ID: 34742742
[TBL] [Abstract][Full Text] [Related]
7. Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.
Stoltz K; Sinyuk M; Hale JS; Wu Q; Otvos B; Walker K; Vasanji A; Rich JN; Hjelmeland AB; Lathia JD
Neuro Oncol; 2015 Mar; 17(3):361-71. PubMed ID: 25416826
[TBL] [Abstract][Full Text] [Related]
8. Sox2 is associated with cancer stem-like properties in colorectal cancer.
Takeda K; Mizushima T; Yokoyama Y; Hirose H; Wu X; Qian Y; Ikehata K; Miyoshi N; Takahashi H; Haraguchi N; Hata T; Matsuda C; Doki Y; Mori M; Yamamoto H
Sci Rep; 2018 Dec; 8(1):17639. PubMed ID: 30518951
[TBL] [Abstract][Full Text] [Related]
9. RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial-mesenchymal transition via MAPK/SOX2 pathway in bladder cancer.
Hui K; Gao Y; Huang J; Xu S; Wang B; Zeng J; Fan J; Wang X; Yue Y; Wu S; Hsieh JT; He D; Wu K
Cell Death Dis; 2017 Feb; 8(2):e2600. PubMed ID: 28182001
[TBL] [Abstract][Full Text] [Related]
10. The Role of Castration-Resistant Bmi1+Sox2+ Cells in Driving Recurrence in Prostate Cancer.
Yoo YA; Vatapalli R; Lysy B; Mok H; Desouki MM; Abdulkadir SA
J Natl Cancer Inst; 2019 Mar; 111(3):311-321. PubMed ID: 30312426
[TBL] [Abstract][Full Text] [Related]
11. Arsenic promotes the COX2/PGE2-SOX2 axis to increase the malignant stemness properties of urothelial cells.
Ooki A; Begum A; Marchionni L; VandenBussche CJ; Mao S; Kates M; Hoque MO
Int J Cancer; 2018 Jul; 143(1):113-126. PubMed ID: 29396848
[TBL] [Abstract][Full Text] [Related]
12. CD59 Regulation by SOX2 Is Required for Epithelial Cancer Stem Cells to Evade Complement Surveillance.
Chen J; Ding P; Li L; Gu H; Zhang X; Zhang L; Wang N; Gan L; Wang Q; Zhang W; Hu W
Stem Cell Reports; 2017 Jan; 8(1):140-151. PubMed ID: 28017655
[TBL] [Abstract][Full Text] [Related]
13. Targeting of replicating CD133 and OCT4/SOX2 expressing glioma stem cells selects a cell population that reinitiates tumors upon release of therapeutic pressure.
Guerra-Rebollo M; Garrido C; Sánchez-Cid L; Soler-Botija C; Meca-Cortés O; Rubio N; Blanco J
Sci Rep; 2019 Jul; 9(1):9549. PubMed ID: 31267022
[TBL] [Abstract][Full Text] [Related]
14. The dark side of SOX2: cancer - a comprehensive overview.
Wuebben EL; Rizzino A
Oncotarget; 2017 Jul; 8(27):44917-44943. PubMed ID: 28388544
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional repressor GATA binding 1-mediated repression of SRY-box 2 expression suppresses cancer stem cell functions and tumor initiation.
Gong X; Liu W; Wu L; Ma Z; Wang Y; Yu S; Zhang J; Xie H; Wei G; Ma F; Lu L; Chen L
J Biol Chem; 2018 Nov; 293(48):18646-18654. PubMed ID: 30315105
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice.
Skoda J; Nunukova A; Loja T; Zambo I; Neradil J; Mudry P; Zitterbart K; Hermanova M; Hampl A; Sterba J; Veselska R
Tumour Biol; 2016 Jul; 37(7):9535-48. PubMed ID: 26790443
[TBL] [Abstract][Full Text] [Related]
17. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
[TBL] [Abstract][Full Text] [Related]
18. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C
Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909
[TBL] [Abstract][Full Text] [Related]
19. Functional and molecular characterization of cancer stem-like cells in bladder cancer: a potential signature for muscle-invasive tumors.
Ferreira-Teixeira M; Parada B; Rodrigues-Santos P; Alves V; Ramalho JS; Caramelo F; Sousa V; Reis F; Gomes CM
Oncotarget; 2015 Nov; 6(34):36185-201. PubMed ID: 26452033
[TBL] [Abstract][Full Text] [Related]
20. Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells.
Yang YM; Chang JW
Cancer Invest; 2008 Aug; 26(7):725-33. PubMed ID: 18608209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
